Truvestments Capital’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.02K | Hold |
265
| – | – | ﹤0.01% | 879 |
|
2025
Q1 | $1.52K | Hold |
265
| – | – | ﹤0.01% | 898 |
|
2024
Q4 | $1.32K | Hold |
265
| – | – | ﹤0.01% | 896 |
|
2024
Q3 | $1.43K | Buy |
+265
| New | +$1.43K | ﹤0.01% | 829 |
|
2024
Q2 | – | Sell |
-265
| Closed | -$867 | – | 238 |
|
2024
Q1 | $867 | Hold |
265
| – | – | ﹤0.01% | 657 |
|
2023
Q4 | $930 | Hold |
265
| – | – | ﹤0.01% | 714 |
|
2023
Q3 | $1.77K | Hold |
265
| – | – | ﹤0.01% | 597 |
|
2023
Q2 | $2.22K | Hold |
265
| – | – | ﹤0.01% | 595 |
|
2023
Q1 | $2.63K | Sell |
265
-664
| -71% | -$6.59K | ﹤0.01% | 560 |
|
2022
Q4 | $6.47K | Hold |
929
| – | – | ﹤0.01% | 513 |
|
2022
Q3 | $5K | Hold |
929
| – | – | ﹤0.01% | 463 |
|
2022
Q2 | $4K | Buy |
+929
| New | +$4K | ﹤0.01% | 489 |
|
2022
Q1 | – | Sell |
-419
| Closed | -$2K | – | 194 |
|
2021
Q4 | $2K | Hold |
419
| – | – | ﹤0.01% | 544 |
|
2021
Q3 | $4K | Hold |
419
| – | – | ﹤0.01% | 464 |
|
2021
Q2 | $5K | Hold |
419
| – | – | ﹤0.01% | 451 |
|
2021
Q1 | $5K | Sell |
419
-114
| -21% | -$1.36K | ﹤0.01% | 516 |
|
2020
Q4 | $3K | Buy |
+533
| New | +$3K | ﹤0.01% | 522 |
|
2020
Q3 | – | Sell |
-533
| Closed | -$2K | – | 322 |
|
2020
Q2 | $2K | Buy |
+533
| New | +$2K | ﹤0.01% | 502 |
|
2019
Q4 | – | Sell |
-936
| Closed | -$5K | – | 154 |
|
2019
Q3 | $5K | Sell |
936
-54
| -5% | -$288 | ﹤0.01% | 564 |
|
2019
Q2 | $6K | Hold |
990
| – | – | ﹤0.01% | 588 |
|
2019
Q1 | $9K | Buy |
+990
| New | +$9K | 0.01% | 527 |
|
2018
Q3 | $15K | Buy |
+1,065
| New | +$15K | 0.01% | 564 |
|